HOC is our outreach and engagement site which connects us with healthcare professionals, industry personnel and academics worldwide.
Our HOC platform shares blogs from experienced medical writers around the world, bringing you tips on good communication, evaluations of current health economics and outcomes research and healthcare evidence. Mixed in with great information you will find a light-hearted approach to current issues, some valuable downloads, as well as references for further reading.
heor.tv inteviewed Marilyn Dix Smith, Founding Executive Director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and asked How was ISPOR founded and how much has it changed over the years?
Details
heor.tv inteviewed Marilyn Dix Smith, Founding Executive Director of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and asked about its impact on patient healthcare.
Details
‘Ghostwriting’ is a contentious issue among both medical practitioners and medical writers. Outside these circles, this issue typically only surfaces when either a politician decides to deplore it or a pharmaceutical company is implicated.
Details
The statistics are staggering. According to one study, the average office worker is interrupted every 11 minutes and takes 25 minutes to return to the original task. Another estimate is…
Details
Duncan Dibble and Ruth Whittington speak to Jeff Trotter about observational research and its place in the changing health technology assessment (HTA) environment. heor.tv is a collaboration between http://www.healtheconomicsdigest.com and https://rxcomms.com
Details
heor.tv interview Diana Brixner, former president of ISPOR and asked her how important good communications are with respect to rational decision making in the context of evidence supporting market access and reimbursement.
Details
Duncan Dibble interviewed Judith Hargreaves, Associate Director for Global Health Economics and Outcomes Research at Ethicon Products about her approach to the customer base in light of the Health Technology Assessment (HTA) landscape.
Details
heor.tv polled Mark Sculpher and Ameet Bakhai with regards to what value based pricing means to them by providing some perspective on the subject.
Details
As part of the heor.tv inteview with Jim Furniss, they asked about his thoughts on Value Based Pricing in the UK and what considerations should be mindful of before implementation in 2014.
Details
heor.tv interviewed Jim Furniss, Director of Market Access at Bridgehead International and asked what effect the global recession has had on pricing, reimbursement and market access.
Details
